化学疗法诱导的恶心和吐的研究趋势:一个图书统计分析
Chunhui Ning1, Yunzi Yan2, Yansong Wang2
1Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Frontiers in pharmacology
|September 30, 2024
概括
这项研究分析了2012-2022年化学疗法诱导的恶心和吐 (CINV) 的846篇出版物. 研究主要集中在药物治疗上,如palonosetron和抗emetic受体对抗剂.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 图书统计学 图书统计学
背景情况:
- 化疗诱导的恶心和吐 (CINV) 是癌症治疗的显著不良影响.
- 尽管进行了广泛的研究,但了解CINV病理生理学和研究趋势至关重要.
- 为了绘制CINV的全球研究格局,需要进行文献计量分析.
研究的目的:
- 评估CINV研究的发展情况.
- 检查研究模式并确定关键领域.
- 为了衡量CINV研究成果的全球扩张.
主要方法:
- 对2012年至2022年间发表的846篇CINV文章进行了图书统计分析.
- 数据来源于网络科学核心集合.
- 用于知识映射和趋势分析的CiteSpace和VOSviewer.
主要成果:
- 美国领先于出版 (28.01%). 多伦多大学是最具生产力的机构.
- 关键的研究主题包括"帕洛诺塞特朗"",中度发性化疗"",5-HT3受体对抗剂"和"神经基因素1受体对抗剂".
- 研究主要集中在针对CINV.的药理干预措施上.
结论:
- 图书统计分析为CINV的研究趋势提供了深刻的见解.
- 结果可以指导研究人员识别新兴的边界和CINV研究中的关键信息.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
152
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
152
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
179
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
179
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
203
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
203
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Pathophysiology of Vomiting
333
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
333
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


